Dr. James Michael Orms, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8812 Hwy 79 West, Jewett, TX 75846 Phone: 903-626-1687 Fax: 833-672-2931 |
News Archive
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
Farming techniques must adapt to mitigate the effects of climate change and ensure global food security, Olivier De Schutter, the U.N. special rapporteur on the right to food, said in a statement to mark Saturday's World Food Day, Agence France-Presse reports.
In a counter-intuitive finding, scientists at New York University (NYU) and Polytechnic Institute of New York University (NYU-Poly) report that the foam used in helmets and other body armor indeed absorbs damage when compressed slowly but can cause as much injury as a hard object when hit at high speeds.
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
In preclinical experiments, investigators restored p53 using synthetic mRNA nanoparticles, making lung and liver cancer cells susceptible to available cancer drugs.
› Verified 2 days ago